Suchergebnisse - "Pasternak, Amy L"

PubPharm (42)

1

Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles

enthalten in: Clinical pharmacology and therapeutics | 2024

von Granados, J. | Pasternak, A. | Henry, N. | +2

2

Risk of Toxicity From Topical5‐Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles

enthalten in: Clinical Pharmacology & Therapeutics | 2024

von Granados, J. | Pasternak, A. | Henry, N. | +2

3

Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository

enthalten in: Clinical pharmacology and therapeutics | 2023

von Pasternak, A. | Seda, R. | Lipa, J. | +9

4

Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services

enthalten in: Clinical and translational science | 2023

von Pasternak, A. | Ward, K. | Irwin, M. | +7

5

Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant Recipients

enthalten in: Therapeutic drug monitoring | 2023

von Pasternak, A. | Park, J. | Pai, M.

6

Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Pasternak, A. | Seda, R. | Lipa, J. | +9

7

Identifying the prevalence of clinically actionable drug‐gene interactions in a health system biorepository to guide pharmacogenetics implementation services

enthalten in: Clinical and Translational Science | 2023

von Pasternak, A. | Ward, K. | Irwin, M. | +7

8

Survey of US Medical Oncologists' Practices and Beliefs Regarding DPYD Testing Before Fluoropyrimidine Chemotherapy

enthalten in: JCO oncology practice | 2022

von Koo, K. | Pasternak, A. | Henry, N. | +2

9

Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research : application to the implementation of pharmacogenetic testing for antidepressant therapy

enthalten in: Implementation science communications | 2022

von Salloum, R. | Bishop, J. | Elchynski, A. | +25

10

Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy

enthalten in: Implementation science communications | 2022

von Salloum, R. | Bishop, J. | Elchynski, A. | +25

1
2
3
4
5
Nächster »
[5]